Skip to content
EU Parl WatchResearch
Projects

Dossiers

Dossiers: Health

Every dossier Parliament took a decision on this term — laws, consent files, budget and own-initiative files — with its stage and its decisions in plenary.

Clear filters

34 dossiers

Export
Type, Lead: procedure type and lead committee (tap for the name). Stage: where the file stands in the procedure. Decisions: decisions Parliament took on it this term. Period: first and latest decision; the latest decision's effect under it.
DossierTypeStageLeadDecisions, sort most firstPeriod, sort oldest first
Narco-trafficking in Europe’s waters: protecting our borders and supporting our law enforcement officers 2026/2797(RSP)RSPFirst readingDecisions117 Sept 2026 Latest: Adopted
Strengthening global health resilience in partner countries 2026/2731(RSP)RSPFirst readingDEVEDecisions117 Sept 2026 Latest: Adopted
An EU health workforce crisis plan: sustainability of healthcare systems and employment and working conditions in the healthcare sector 2025/2062(INI)INIFirst readingSANTDecisions117 Sept 2026 Latest: Adopted
An EU cardiovascular diseases strategy 2025/2132(INI)INIFirst readingSANTDecisions116 Sept 2026 Latest: Adopted
Gender inequalities in health, specifically as regards gender-specific conditions 2025/2074(INI)INIFirst readingFEMMDecisions116 Sept 2026 Latest: Adopted
Objection pursuant to Rule 115(2) and (3) of the Rules of Procedures on the Commission Implementing Decision authorising the placing on the market of products containing, consisting of or produced from genetically modified maize DP202216 x NK603 x DAS-40278-9 and its sub-combinations DP202216 x NK603, DP202216 x DAS-40278-9, pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council (D114997) 2026/2746(RSP)RSPFirst readingENVIDecisions18 Jul 2026 Latest: Objection passed
Implementation of the Urban Wastewater Treatment Directive (UWWTD) and risks to the security of supply of medicines 2026/2652(RSP)RSPFirst readingDecisions118 Jun 2026 Latest: Adopted
Amending Directive (EU) 2020/262 as regards the general arrangements for excise duty in respect of tobacco and tobacco related products 2025/0581(CNS)CNSFirst readingECONDecisions117 Jun 2026 Latest: Passed
Structure and rates of excise duty applied to tobacco and tobacco related products (recast) 2025/0580(CNS)CNSFirst readingECONDecisions117 Jun 2026 Latest: Failed
Motion for a resolution on the need to reduce work-related fatalities 2025/3046(RSP)RSPFirst readingEMPLDecisions121 May 2026 Latest: Adopted
World Cancer Day 2026/2586(RSP)RSPFirst readingDecisions112 Feb 2026 Latest: Adopted
Murder of Mehdi Kessaci - urgent need for ambitious European action against drug trafficking 2025/3020(RSP)RSPFirst readingDecisions120 Jan 2026 Latest: Adopted
Laying a framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest, and amending Regulation (EU) 2024/795 2025/0102(COD)CODFirst readingSANTDecisions120 Jan 2026 Latest: Passed
European Citizens’ Initiative 'My voice, my choice: for safe and accessible abortion' 2025/3007(RSP)RSPFirst readingFEMMDecisions117 Dec 2025 Latest: Adopted
Objection pursuant to Rule 115(2) and (3) of the Rules of Procedure to the draft Commission Implementing Decision renewing the authorisation for the placing on the market of products containing, consisting of or produced from genetically modified maize NK603 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council 2025/2958(RSP)RSPFirst readingENVIDecisions116 Dec 2025 Latest: Objection passed
Objection pursuant to Rule 115(2) and (3) of the Rules of Procedure to the draft Commission Implementing Decision authorising the placing on the market of products containing, consisting of or produced from of genetically modified maize DAS1131, pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council 2025/2893(RSP)RSPFirst readingENVIDecisions125 Nov 2025 Latest: Objection passed
Objection pursuant to Rule 115(2) and (3) of the Rules of Procedure to the draft Commission Implementing Decision authorising the placing on the market of products containing, consisting of or produced from genetically modified maize DP51291 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council 2025/2807(RSP)RSPFirst readingENVIDecisions18 Oct 2025 Latest: Objection passed
Amending Regulation (EU) 2023/1542 as regards obligations of economic operators concerning battery due diligence policies 2025/0129(COD)CODFirst readingENVIDecisions110 Jul 2025 Latest: Passed
Amendments to the International Health Regulations contained in the Annex to Resolution WHA77.17 and adopted on 1 June 2024 2024/0299(NLE)NLEFirst readingSANTDecisions16 May 2025 Latest: Consent given
Objection pursuant to Rule 115(2) and (3) authorising the placing on the market of products containing, consisting of or produced from genetically modified maize MON 95275 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council 2024/3011(RSP)RSPFirst readingENVIDecisions112 Feb 2025 Latest: Objection passed
Objection pursuant to Rule 115(2) and (3) authorising the placing on the market of products containing, consisting of or produced from genetically modified maize DP910521 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council 2024/3010(RSP)RSPFirst readingENVIDecisions112 Feb 2025 Latest: Objection passed
Amendment of Annex VI – Powers and responsibilities of the standing committees 2024/2115(RSO)RSOFirst readingDecisions118 Dec 2024 Latest: Adopted
Recommendation on smoke- and aerosol-free environments 2024/2911(RSP)RSPFirst readingDecisions128 Nov 2024 Latest: Rejected
Objection pursuant to Rule 115(2) and (3) D099729 – authorising the placing on the market of products containing, consisting of or produced from genetically modified MON 94804, pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council 2024/2841(RSP)RSPFirst readingENVIDecisions126 Nov 2024 Latest: Objection passed
Objection pursuant to Rule 115(2) and (3) D096832 - renewing the authorisation for the placing on the market of feed containing, consisting of and of food and feed products produced from genetically modified maize MON 810, pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council and repealing Commission Implementing Decision (EU) 2017/1207 2024/2840(RSP)RSPFirst readingENVIDecisions126 Nov 2024 Latest: Objection passed
Objection pursuant to Rule 115(2) and (3) D096836 - authorising the placing on the market of products containing, consisting of or produced from genetically modified maize DP-915635-4, pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council 2024/2839(RSP)RSPFirst readingENVIDecisions126 Nov 2024 Latest: Objection passed
Objection pursuant to Rule 115(2) and (3) D096838 - authorising the placing on the market of products containing, consisting of or produced from genetically modified maize DP-023211-2, pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council 2024/2838(RSP)RSPFirst readingENVIDecisions126 Nov 2024 Latest: Objection passed
Objection pursuant to Rule 115(2) and (3) D098501 – authorising the placing on the market of products containing, consisting of or produced from genetically modified maize DP202216, pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council 2024/2837(RSP)RSPFirst readingENVIDecisions126 Nov 2024 Latest: Objection passed
Objection pursuant to Rule 115(2) and (3) renewing the authorisation for the placing on the market of products containing, consisting of or produced from genetically modified maize MON 89034 × 1507 × NK603, pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council 2024/2836(RSP)RSPFirst readingENVIDecisions126 Nov 2024 Latest: Objection passed
Objection pursuant to Rule 115(2) and (3) renewing the authorisation for the placing on the market of products containing, consisting of or produced from genetically modified maize MON 89034 × 1507 × MON 88017 x 59122 and eight sub-combinations, pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council 2024/2834(RSP)RSPFirst readingENVIDecisions126 Nov 2024 Latest: Objection passed
Urgent need to revise the medical devices regulation 2024/2849(RSP)RSPFirst readingDecisions123 Oct 2024 Latest: Adopted
The devastating floods in Central and Eastern Europe, the loss of lives and the EU’s preparedness to act on such disasters exacerbated by climate change 2024/2817(RSP)RSPFirst readingDecisions119 Sept 2024 Latest: Adopted
Commission Regulation amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for cyproconazole and spirodiclofen in or on certain products 2024/2759(RPS)RPSFirst readingENVIDecisions118 Sept 2024 Latest: Objection passed
Commission Regulation amending Annexes II, III and V to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for benomyl, carbendazim and thiophanate‐methyl in or on certain products 2024/2758(RPS)RPSFirst readingENVIDecisions118 Sept 2024 Latest: Objection passed